Anti-Saccharomyces cerevisiae Antibodies in Rheumatoid Arthritis

被引：5

作者：

Melayah, Sarra ^{[1
,2
]}

Ghozzi, Mariem ^{[1
,2
]}

Jemni, Malek ^{[1
,2
]}

Sakly, Nabil ^{[2
,3
]}

Ghedira, Ibtissem ^{[1
,2
]}

Mankai, Amani ^{[1
,4
]}

机构：

[1] Farhat Hached Hosp, Lab Immunol, Sousse, Tunisia

[2] Monastir Univ, Fac Pharm, Dept Immunol, Monastir, Tunisia

[3] Fattouma Bourguiba Hosp, Lab Immunol, Monastir, Tunisia

[4] Tunis El Manar Univ, High Sch Sci & Tech Hlth, Tunis, Tunisia

来源：

LABORATORY MEDICINE | 2022年 / 53卷 / 06期

关键词：

anti-Saccharomyces cerevisiae antibodies; phosphopeptidomannan; rheumatoid arthritis; anti-CCP antibodies; rheumatoid factors; autoimmune disease; ANKYLOSING-SPONDYLITIS; CLASSIFICATION; DIAGNOSIS; MANNAN; LECTIN; ASCA; IGA;

D O I：

10.1093/labmed/lmac054

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

Objective This study was conducted to evaluate the frequency of anti-Saccharomyces cerevisiae antibodies (ASCA) in patients with rheumatoid arthritis (RA). Methods Eighty-three RA patients with positive anti-cyclic citrullinated antibodies (anti-CCP) and 160 healthy blood donors were included in this study. ASCA IgG and IgA were assessed with enzyme-linked immunosorbent assay. Results The frequency of ASCA was significantly higher in RA patients than in healthy subjects (22.9% vs 3.7%, P < 10(-3)). Both ASCA IgG and ASCA IgA were significantly more frequent in RA patients than in the control group (20.5% vs 3.1%, P < 10(-3)and 9.6% vs 0.6%, P = .002, respectively). ASCA IgG and ASCA IgA levels were significantly higher in RA patients than in healthy subjects (7.8 +/- 8.4 U/mL vs 2.3 +/- 2.8 U/mL, P < 10(-6) and 6.2 +/- 10.9 U/mL vs 3.4 +/- 1.7 U/mL, P = .002, respectively). Conclusion A high frequency of ASCA IgG and ASCA IgA has been found in RA patients.

引用

页码：585 / 589

页数：5

共 50 条

[1] Anti-saccharomyces cerevisiae antibodies and coeliac disease
Candelli, M
Nista, EC
Carloni, E
Pignataro, G
Rigante, D
Gasbarrini, A
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2003, 38 (11) : 1191 - 1192
[2] Anti-Saccharomyces cerevisiae antibodies in coeliac disease
Toumi, Dorsaf
Mankai, Amani
Belhadj, Ramla
Ghedira-Besbes, Leila
Jeddi, Moncef
Ghedira, Ibtissem
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2007, 42 (07) : 821 - 826
[3] Anti-saccharomyces cerevisiae antibodies are raised in IgA nephropathy
Szelestei, Tamas
Vas, Tibor
Szigeti, Nora
Degrell, Peter
Berki, Timea
Sarlos, Patricia
Wittmann, Istvan
Nagy, Judit
Kovacs, Tibor
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 285 - 285
[4] Prevalence of anti-Saccharomyces cerevisiae antibodies in celiac patients
Motta, Estela
Capristo, Rocio
Franco, Micaela
ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2018, 52 (04): : 417 - 422
[5] Anti-saccharomyces cerevisiae antibodies in ankylosing spondylitis.
Hoffman, IEA
Veys, EM
Peeters, M
De Vos, M
Mielants, H
De Keyser, F
ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S236 - S236
[6] Anti-Saccharomyces cerevisiae antibodies in primary biliary cirrhosis
Sakly, Wahiba
Jeddi, Moncef
Ghedira, Ibtissem
DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (07) : 1983 - 1987
[7] Anti-Saccharomyces cerevisiae Antibodies in Primary Biliary Cirrhosis
Wahiba Sakly
Moncef Jeddi
Ibtissem Ghedira
Digestive Diseases and Sciences, 2008, 53 : 1983 - 1987
[8] Anti-Saccharomyces cerevisiae antibodies (ASCA) in spondyloarthropathies:: a reassessment
Aydin, S. Z.
Atagunduz, P.
Temel, M.
Bicakcigil, M.
Tasan, D.
Direskeneli, H.
RHEUMATOLOGY, 2008, 47 (02) : 142 - 144
[9] Anti-Saccharomyces cerevisiae antibodies in acute myocardial infarction
Cinemre, Hakan
Bilir, Cemil
Gokosmanoglu, Feyzi
Kadakal, Figen
JOURNAL OF INVESTIGATIVE MEDICINE, 2007, 55 (08) : 444 - 449
[10] Anti-saccharomyces cerevisiae antibodies (ASCA) in coeliac disease
Granito, A
Muratori, L
Muratori, P
Guidi, M
Lenzi, M
Bianchi, FB
Volta, U
GUT, 2006, 55 (02) : 296 - 296

← 1 2 3 4 5 →